References

  1. Westhoff CM et al. A new hybrid RHCE gene (CeNR) is responsible for expression of a novel antigen. Transfusion, 2004. [Citation] [RHeference]
  2. Flegel WA et al. The RHCE allele ceCF: the molecular basis of Crawford (RH43). Transfusion, 2006. [Citation] [RHeference]
  3. Westhoff CM et al. Rh complexities: serology and DNA genotyping. Transfusion, 2007. [Citation] [RHeference]
  4. S Vege et al. RHD Exon Consensus Splice-Site Changes, 334A>G and 1228T>G, Associated with Weak D Expression Transfusion, 2009. — Abstract — [RHeference]
  5. Westhoff CM et al. DIIIa and DIII Type 5 are encoded by the same allele and are associated with altered RHCE*ce alleles: clinical implications. Transfusion, 2010. [Citation] [RHeference]
  6. Hipsky CH et al. RHCE*ceCF encodes partial c and partial e but not CELO, an antigen antithetical to Crawford. Transfusion, 2011. [Citation] [RHeference]
  7. S Vege et al. Weak D Type 2 and Production of Anti-D Transfusion, 2011. — Abstract — [RHeference]
  8. C Lomas-Francis et al. Surprising findings with RBCs expressing the low prevalence RH antigen Evans Transfusion, 2011. — Abstract — [RHeference]
  9. Hue-Roye K et al. Red cells from the original JAL+ proband are also DAK+ and STEM+. Vox Sang, 2011. [Citation] [RHeference]
  10. C Fong et al. An RHD*455C Allele Encodes a Partial D Phenotype Associated With Production of Allo Anti-D Transfusion, 2012. — Abstract — [RHeference]
  11. Westhoff CM et al. RHCE*ceTI encodes partial c and partial e and is often in cis to RHD*DIVa. Transfusion, 2013. [Citation] [RHeference]
  12. Westhoff CM et al. RHCE*ceMO is frequently in cis to RHD*DAU0 and encodes a hr(S) -, hr(B) -, RH:-61 phenotype in black persons: clinical significance. Transfusion, 2013. [Citation] [RHeference]
  13. Chou ST et al. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood, 2013. [Citation] [RHeference]
  14. C M Westhoff et al. A Weak D Phenotype Discovered in Nine Patients in Western Canada due to a Nucleotide 1187C>G (Pro396Arg) Change in RHD Transfusion, 2014. — Abstract — [RHeference]
  15. G Shakarian et al. Three New, Clinically Relevant RHD genes Transfusion, 2014. — Abstract — [RHeference]
  16. Ipe TS et al. Severe hemolytic transfusion reaction due to anti-D in a D+ patient with sickle cell disease. J Pediatr Hematol Oncol, 2015. [Citation] [RHeference]
  17. Sandler SG et al. It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group. Transfusion, 2015. [Citation] [RHeference]
  18. Haspel RL et al. How do I manage Rh typing in obstetric patients? Transfusion, 2015. [Citation] [RHeference]
  19. Vege S et al. D typing discrepancies and anti-D production associated with six new RHD alleles. Transfusion, 2016. — Abstract — [RHeference]
  20. Chou ST et al. Application of genomics for transfusion therapy in sickle cell anemia. Blood Cells Mol Dis, 2017. [Citation] [RHeference]
  21. J P Hudgins et al. Serologic and Molecular Classification of a Novel RHD Allele Transfusion, 2017. — Abstract — [RHeference]
  22. S Vege et al. Expansion of the RHD DAU Cluster: Identification of Two Additional Novel Alleles Transfusion, 2017. — Abstract — [RHeference]
  23. S Vege et al. Serologic Characterization of D Antigen Expression Encoded By Two Reported RHD Alleles: Implications for Transfusion and Pregnancy Transfusion, 2017. — Abstract — [RHeference]
  24. S Vege et al. RHD Genotyping of Discrepant or Weak D Samples: Over a Year’s Experience. Transfusion, 2017. — Abstract — [RHeference]
  25. J Aeschlimann et al. Gene Conversion within the r’S Haplotype Complicates RHD Genotype Interpretations Transfusion, 2017. — Abstract — [RHeference]
  26. Chou ST et al. Whole-exome sequencing for RH genotyping and alloimmunization risk in children with sickle cell anemia. Blood Adv, 2017. [Citation] [RHeference]
  27. J Aeschlimann et al. Serological and Molecular Characterization of Three New RHD Alleles Transfusion, 2018. — Abstract — [RHeference]
  28. J S. Woo et al. Robust Allo-Anti-D with Subsequent Anti-K Production after Transfusion of D-Positive RBCs to a Patient with Weak D Type 1 Transfusion, 2018. — Abstract — [RHeference]
  29. Aeschlimann J et al. Four novel silenced RHCE. Transfusion, 2018. [Citation] [RHeference]
  30. Sunitha Vege et al. Novel RHD Alleles Identified When Resolving Serologic Weak D Phenotypes Transfusion, 2019. — Abstract — [RHeference]
  31. Westhoff CM et al. Experience with RHD*weak D type 4.0 in the USA. Blood Transfus, 2019. [Citation] [RHeference]
  32. Mathur G et al. A novel RHD*DAU allele with c.1136C>T (p.Thr379Met) and c.17C>T (p. Pro6Leu). Transfusion, 2020. [Citation] [RHeference]
  33. Sunitha Vege et al. Novel RHD Alleles and Predicting Risk for Anti-D Transfusion, 2020. — Abstract — [RHeference]
  34. Sunitha Vege et al. Novel RHCE*ceS with c.462G>T (p. Arg154Ser) Encodes Expression of a D Reactive Epitope Transfusion, 2020. — Abstract — [RHeference]
  35. Vege S et al. Impact of RHD genotyping on transfusion practice in Denmark and the United States and identification of novel RHD alleles. Transfusion, 2021. [Citation] [RHeference]